as on January 23, 2026 at 2:29 am IST
Day's Low
Day's High
0.64%
Downside
8.08%
Upside
52 Week's Low
52 Week's High
61.86%
Downside
302.24%
Upside
Check Moonlake Immunotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-3.5999
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-227.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-54.33%
Compare market cap, revenue, PE, and other key metrics of Moonlake Immunotherapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | NA | NA | 0.00% | |
| BUY | $48.3B | 114.64% | 1260.21 | 1.36% | |
| BUY | $118.2B | 96.7% | 32.47 | 31.35% | |
| NA | $37.8B | NA | 669.88 | 1.38% | |
| BUY | $79.4B | 40.49% | 17.95 | 32.13% |
The Moonlake Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moonlake Immunotherapeutics investment value today
Current value as on today
₹39,189
Returns
Returns from Moonlake Immunotherapeutics Stock
Dollar Returns*
₹5,913 (+5.91%)
Based on 22 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 22 analysts, 81.82% of analysts recommend a 'BUY' rating for Moonlake Immunotherapeutics. Average target price of $18.63
Get share price movements and forecasts by analysts on Moonlake Immunotherapeutics.
What analysts predicted
16.26%UPSIDE
Target Price
$18.63
Current Price
$15.6
Analyzed by
22 Analysts
Target
$18.63
Moonlake Immunotherapeutics target price $18.63, a slight upside of 16.26% compared to current price of $15.6. According to 22 analysts rating.
Investment in Moonlake Immunotherapeutics Shares on INDmoney has grown by 91.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:91.00% versus previous 30 day period
Search interest for Moonlake Immunotherapeutics Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:67% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, MLTX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 52.5% return, outperforming this stock by 119.2%
Price Dip
![]()
In the last 7 days, MLTX stock has moved down by -6.8%
| Organisation | Moonlake Immunotherapeutics |
| Headquarters | Dorfstrasse 29, Zug, Switzerland, 6300 |
| CEO | Dr. Jorge Santos da Silva Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Jorge Santos da Silva Ph.D. | Co-Founder, CEO & Director |
Mr. Matthias Bodenstedt | Chief Financial Officer |
Joana Cortez | Senior Director Legal & Compliance |
Tino Anthamatten | Vice President of Marketing, Market Access & Pricing |
Dr. Kristian Reich M.D., Ph.D. | Co-Founder & Chief Scientific Officer |
Mr. Oliver Daltrop Ph.D. | Chief Operations Officer |
Ms. Carla Bretes | Director of Investor Relations & External Communications |
Mr. Nicolas Mosimann Ph.D. | General Counsel |
Luciana Marques | Director of HR, People & Culture |
Ms. Nuala Brennan | Chief Clinical Development Officer |
Moonlake Immunotherapeutics share price today is $15.6 as on at the close of the market. Moonlake Immunotherapeutics share today touched a day high of $16.86 and a low of $15.5.
Moonlake Immunotherapeutics share touched a 52 week high of $62.75 on and a 52 week low of $5.95 on . Moonlake Immunotherapeutics stock price today i.e. is closed at $15.6,which is 75.14% down from its 52 week high and 162.18% up from its 52 week low.
Moonlake Immunotherapeutics market capitalisation is $0.00T as on .
Indian investors can start investing in Moonlake Immunotherapeutics (MLTX) shares with as little as ₹91.567 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.67 in Moonlake Immunotherapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moonlake Immunotherapeutics share’s latest price of $15.6 as on January 23, 2026 at 2:29 am IST, you will get 0.6410 shares of Moonlake Immunotherapeutics. Learn more about
fractional shares .